Graham G. Walmsley 4/A
4/A · Olema Pharmaceuticals, Inc. · Filed May 13, 2025
Insider Transaction Report
Form 4/AAmended
Graham G. Walmsley
Director
Holdings
- 1,800,000(indirect: See note)
Common Stock
Footnotes (1)
- [F1]These securities are held by Logos Global Master Fund LP ("Logos Master Fund"). This holding was inadvertently omitted from the Form 4 filed by the reporting person on December 17, 2024. Logos Master Fund did not participate in the transactions reported in that Form 4. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.